B/BE/21/BVW3 - Information sheet for the public (prepared by the notifier)

File: 
Icône PDF bbe21bvw3_pub_en.pdf
Trial reference: 
Phase I/II study to evaluate the safety and effects on Progranulin levels of PR006 in patients with Fronto-Temporal Dementia with Progranulin mutations (FTD-GRN).
Doc type: 
Information for the public